Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for pharmaceutical industry professionals · Monday, September 30, 2024 · 747,630,518 Articles · 3+ Million Readers

Lisinopril Global Market 2024 To Reach $2.26 Billion By 2028 At Rate Of 6.4%

Lisinopril Global Market Report 2024

Lisinopril Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company's Lisinopril Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

https://www.thebusinessresearchcompany.com/”
— The Business Research Company

LONDON, GREATER LONDON, UK, August 20, 2024 /EINPresswire.com/ -- The lisinopril market has experienced robust growth in recent years, expanding from $1.66 billion in 2023 to $1.76 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to increased accessibility, lifestyle shifts, increased screening programs, increased accessibility of generic lisinopril, and increased patient adherence.

Strong Future Growth Anticipated
The lisinopril market is projected to continue its strong growth, reaching $2.26 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising prevalence of hypertension and cardiovascular diseases, generic versions and cost-effectiveness, growing awareness and early diagnosis, growing demand for effective treatments, and aging population.

Explore Comprehensive Insights Into The Global Lisinopril Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=16465&type=smp

Growth Driver Of The Lisinopril Market
The growing prevalence of cardiovascular diseases is expected to propel the growth of the lisinopril market going forward. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels. The growing prevalence of cardiovascular diseases can be attributed to several factors, such as population growth and aging, risk factors, and lack of implementation of proven prevention and treatment strategies. Lisinopril helps manage cardiovascular diseases primarily through its ability to lower blood pressure and reduce the strain on the heart and kidneys. This inhibits the production of angiotensin II, facilitates the dilation of blood vessels, reduces blood volume, and protects organs from damage.

Make Your Report Purchase Here And Explore The Whole Industry's Data As Well:
https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

Major Players And Market Trends
Key players in the lisinopril market include Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc.

Segments:
1) By Brand: Zestoretic, Prinivil, Zestril, Other Brands
2) By Disease: Hypertension, Heart Failure, Heart Attack, Strokes, Diabetic Kidney Disease, Other Diseases
3) By Dosage: Tablet, Liquid, Other Dosages
4) By Population Type: Children, Adults
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Geographical Insights: North America Leading The Market
North America was the largest region in the lisinopril market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Lisinopril Market Definition
Lisinopril is a medication classified as an angiotensin-converting enzyme (ACE) inhibitor. It functions by reducing specific chemicals that constrict blood vessels, promoting smoother blood flow and enhancing the heart's ability to pump blood effectively. Lisinopril is prescribed to adults for the treatment of congestive heart failure and to increase survival rates following a heart attack.

Lisinopril Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Lisinopril Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on lisinopril market size, lisinopril market drivers and trends, lisinopril market major players, lisinopril competitors' revenues, lisinopril market positioning, and lisinopril market growth across geographies. The lisinopril market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Pre-Collision Technology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pre-collision-technology-global-market-report

Auto Collision Estimating Software Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/auto-collision-estimating-software-global-market-report

Auto Collision Repair Management Software Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/auto-collision-repair-management-software-global-market-report

About The Business Research Company?
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+ +44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube

Powered by EIN Presswire

Distribution channels: Business & Economy, Consumer Goods, Healthcare & Pharmaceuticals Industry, International Organizations, World & Regional

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release